Neurorehabilitation Devices Market Size & Share Report - 2032

Neurorehabilitation Devices Market – By Product Type (Neurorobotics, Wearable Devices, BCI, Non-Invasive Stimulators), By Application (Stroke, MS, Parkinsons Disease, Spinal Cord Injury), By End-use (Hospitals, Specialty Clinics) & Forecast, 2024-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; workings

1.3&nbsp;&nbsp;&nbsp; Forecast calculations

1.4&nbsp;&nbsp;&nbsp; Data sources

1.4.1&nbsp;&nbsp;&nbsp; Primary

1.4.2&nbsp;&nbsp;&nbsp; Secondary

1.4.2.1&nbsp;&nbsp;&nbsp; Paid sources

1.4.2.2&nbsp;&nbsp;&nbsp; Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Global neurorehabilitation devices market 3600&nbsp;synopsis, 2018 - 2032

2.1.1&nbsp;&nbsp;&nbsp; Regional trends

2.1.2&nbsp;&nbsp;&nbsp; Product type trends

2.1.3&nbsp;&nbsp;&nbsp; Application trends

2.1.4&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Neurorehabilitation Devices Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Technology landscape

3.3&nbsp;&nbsp;&nbsp; Regulatory landscape

3.4&nbsp;&nbsp;&nbsp; Industry impact forces

3.4.1&nbsp;&nbsp;&nbsp; Growth drivers

3.4.1.1&nbsp;&nbsp;&nbsp; Increasing prevalence of neurological disorders

3.4.1.2&nbsp;&nbsp;&nbsp; Technological advancement in neurorehabilitation devices

3.4.1.3&nbsp;&nbsp;&nbsp; Growing research and development activities regarding neurological disorders

3.4.1.4&nbsp;&nbsp;&nbsp; Rising awareness regarding neurorehabilitation devices

3.4.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.4.2.1&nbsp;&nbsp;&nbsp; High cost of devices

3.4.2.2&nbsp;&nbsp;&nbsp; Stringent regulatory scenario

3.5&nbsp;&nbsp;&nbsp; Growth potential analysis

3.5.1&nbsp;&nbsp;&nbsp; By product type

3.5.2&nbsp;&nbsp;&nbsp; By application

3.5.3&nbsp;&nbsp;&nbsp; By end-use

3.6&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis, 2023

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players, 2023

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix, 2023

4.5&nbsp;&nbsp;&nbsp; Strategic outlook matrix, 2023

Chapter 5&nbsp;&nbsp;&nbsp;Neurorehabilitation Devices Market Size and Forecast, By Product Type, 2018-2032 (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by product type

5.2&nbsp;&nbsp;&nbsp; Neurorobotics

5.3&nbsp;&nbsp;&nbsp; Wearable devices

5.4&nbsp;&nbsp;&nbsp; Brain-computer interface (BCI)

5.5&nbsp;&nbsp;&nbsp; Non-invasive stimulators

5.6&nbsp;&nbsp;&nbsp; Other product types

Chapter 6&nbsp;&nbsp;&nbsp;Neurorehabilitation Devices Market Size and Forecast, By Application, 2018-2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by application

6.2&nbsp;&nbsp;&nbsp; Stroke

6.3&nbsp;&nbsp;&nbsp; Multiple sclerosis (MS)

6.4&nbsp;&nbsp;&nbsp; Parkinson&#39;s disease

6.5&nbsp;&nbsp;&nbsp; Spinal cord injury

6.6&nbsp;&nbsp;&nbsp; Traumatic brain injury

6.7&nbsp;&nbsp;&nbsp; Cerebral palsy

6.8&nbsp;&nbsp;&nbsp; Other applications

Chapter 7&nbsp;&nbsp;&nbsp;Neurorehabilitation Devices Market Size and Forecast, By End-use, 2018-2032 (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Specialty clinics

7.4&nbsp;&nbsp;&nbsp; Other end users

Chapter 8&nbsp;&nbsp;&nbsp;Neurorehabilitation Devices Market Size and Forecast, By Region, 2018-2032 (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by region

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Italy

8.3.5&nbsp;&nbsp;&nbsp; Spain

8.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

8.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.2&nbsp;&nbsp;&nbsp; South Africa

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East &amp; Africa

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Bioventus LLC

9.2&nbsp;&nbsp;&nbsp; Ectron Ltd.

9.3&nbsp;&nbsp;&nbsp; Hocoma (DIH Medical)

9.4&nbsp;&nbsp;&nbsp; BIOMETRICS LTD.

9.5&nbsp;&nbsp;&nbsp; Bionik Laboratories Corp.

9.6&nbsp;&nbsp;&nbsp; BioXtreme Ltd.

9.7&nbsp;&nbsp;&nbsp; Ekso bionics holdings, Inc.

9.8&nbsp;&nbsp;&nbsp; Kinestica

9.9&nbsp;&nbsp;&nbsp; Saebo, Inc.

9.10&nbsp;&nbsp;&nbsp; Abbott Laboratories

9.11&nbsp;&nbsp;&nbsp; Emotiv Inc.

9.12&nbsp;&nbsp;&nbsp; BrainCo, Inc.

9.13&nbsp;&nbsp;&nbsp; Permobil AB

9.14&nbsp;&nbsp;&nbsp; Medtronic Plc

&nbsp;&nbsp;&nbsp;

Neurorehabilitation Devices Market

Customize This Report